The following discussion should be read in conjunction with the financial statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q.





Our Business

Jubilant Flame International, Ltd., (the "Company", "the "Registrant", "we", "us" or "our") was formed on September 29, 2009 under the name Liberty Vision, Inc. The Company provided web development and marketing services for clients. On December 5, 2012, the Company disposed of its subsidiary corporation to a shareholder for a nominal sum, as well as other management operations. On December 16, 2012, the Company changed its name to Jiu Feng Investment Hong Kong, Inc. On January 27, 2013, the Company announced the change of its ticker symbol from "LBYV" to "JFIL." On July 24, 2013, the Company changed its business sector to the medical sector. On August 18, 2015 the Company changed its name to Jubilant Flame International, Ltd.

From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products - in the United States market. In the beginning of 2020, the Company ceased the marketing and selling of cosmetic products in the United States.

From the third quarter of the year ended February 29, 2020, the company began providing technical support services for development of new nutrition food products to sell to customers in USA.





Results of Operations



Revenue

We recognized no sales revenue in the three months ended August 31, 2021 and 2020.





Operating Expenses

For the three months ended August 31, 2021 compared to the three months ended August 31, 2020

The major components of our operating expenses for the three months ended August 31, 2021 and 2020 are outlined in the table below:





                            Three Months       Three Months
                               Ended              Ended
                               Aug 31             Aug 31
                                2021               2020

Officer compensation                4,500              4,500
Professional fee                   10,761             12,325
OTC Filing fees                     3,000              3,000
Other G&A                              72                 48
Total operating expenses   $       18,333     $       19,872

The $1,539 decrease in our operating costs for the three months ended August 31, 2021 compared to three months ended August 31, 2020, was mainly due to a decrease of $1,564 decrease in professional fee.

For the six months ended August 31, 2021 compared to the six months ended August 31, 2020






          3

  Table of Contents

The major components of our operating expenses for the six months ended August 31, 2021 and 2020 are outlined in the table below:





                            Six Months Ended       Six Months Ended
                                 Aug 31                 Aug 31
                                  2021                   2020

Officer compensation                    9,000                  9,000
Selling expense                             -                     18
Professional fee                       25,032                 27,407
OTC Filing fees                         6,000                  6,000
Other G&A                                  72                    548
Total operating expenses   $           40,104     $           42,972

The $2,868 decrease in our operating costs for the six months ended August 31, 2021 compared to six months ended August 31, 2020, was mainly due to a decrease of $2,375 decrease in professional fee.





Other Income

For the three months ended August 31, 2021, we recognized other income of $22,000 compared to zero for the corresponding period in 2020.

For the six months ended August 31, 2021, we recognized other income of $22,243 compared to zero for the corresponding period in 2020.

No other expenses incurred during the three months and six months periods ended August 31, 2021 and 2020.





Net income (Loss)

For the three months ended August 31, 2021, we recognized a net income of $ 3,667 compared to the net loss of $19,872 for the corresponding period in 2020.

For the six months ended August 31, 2021, we recognized a net loss of $ 17,861 compared to the net loss of $42,972 for the corresponding period in 2020.

Liquidity and Capital Resources





Working Capital



                           August 31,      February 28,
                              2021              2021
Current Assets            $     36,996     $      20,825
Current Liabilities       $  1,164,799     $   1,139,767
Working Capital Deficit   $ (1,127,803 )   $  (1,118,942 )





          4

  Table of Contents

As of August 31, 2021, the Company had current assets of $36,996, primarily comprising of cash of $24,612, prepaid expenses of $3,000 and accounts receivable of $9,384, and current liabilities of $1,164,799, resulting in a working capital deficit of $1,127,803. The Company had limited profitable operation activities and has an accumulated deficit of $3,610,084 as of August 31, 2021. This raises substantial doubt about the Company's ability to continue as a going concern.

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

Based on the Company's current operating plan and global coronavirus pandemic impact, the Company does not have sufficient cash and cash equivalents to fund its operations for at least the next twelve months. The Company will need to obtain additional financing to operate our business. The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the nutrition product technology support sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.

Cash Flows from Operating Activities

Our net cash used in operating activities decreased by $40,240 in the six months ended August 31, 2021 of $(5,639) compared to the net cash used in operating activities in the six months ended August 31, 2020 of $ 34,601. The decrease in net cash used in operating activities was primarily the result of a $22,000 shared operating income and a decrease of $15,147 in professional fee payment.

Cash Flows from Investing Activities

We did not generate or use any cash from investing activities during the six months ended August 31, 2021 or 2020.

Cash Flows from Financing Activities

Our cash provided by financing activities decreased from $26,456 for the six months ended August 31, 2020 to $16,532 for the six months ended August 31, 2021. In both periods, cash was provided by the way of loans from related parties.





Future Financing

We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock, through an offering of debt securities, or through borrowings from financial institutions or related parties. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or through a loan from our directors to meet our obligations over the next twelve months.

Off Balance Sheet Arrangements

As of August 31, 2021, we did not have any off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

© Edgar Online, source Glimpses